{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigsoufdgj64ayv4jbdbtwv7fengnbxqlxojl76mifvxp3npaqwm3m",
    "uri": "at://did:plc:vv5cq7qjnr2fd5ytohsyyegf/app.bsky.feed.post/3mmtczcp5krh2"
  },
  "path": "/2026/05/two-drug-molecules-achieve-myelin-repair-in-ms-disease-models/",
  "publishedAt": "2026-05-27T00:00:45.000Z",
  "site": "https://www.optimistdaily.com",
  "tags": [
    "Evergreen",
    "Health",
    "Medicine",
    "Science",
    "Technology",
    "Trending",
    "health",
    "MS nerve damage",
    "MS research 2026",
    "Multiple sclerosis",
    "multiple sclerosis treatment",
    "myelin repair MS",
    "neuroscience",
    "remyelination drugs",
    "Research",
    "Two drug molecules achieve myelin repair in MS disease models",
    "The Optimist Daily: Making Solutions the News"
  ],
  "textContent": "BY THE OPTIMIST DAILY EDITORIAL TEAM Every remyelination drug candidate tested in multiple sclerosis research has failed. A doctoral thesis from the University of Helsinki, defended earlier this month, reports two that didn’t. Tapani Koppinen, working in Associate Professor Merja Voutilainen’s research group, identified two separate drug molecules that successfully triggered myelin regrowth in MS […]\n\nThe post Two drug molecules achieve myelin repair in MS disease models first appeared on The Optimist Daily: Making Solutions the News.",
  "title": "Two drug molecules achieve myelin repair in MS disease models"
}